|
SLC4A1AP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.08149999999518E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.182450E-04 |
| Normal-vs-Stage2 |
2.397000E-03 |
| Normal-vs-Stage3 |
5.51859999999849E-05 |
| Normal-vs-Stage4 |
5.53690000000273E-05 |
| Stage1-vs-Stage2 |
7.987000E-01 |
| Stage1-vs-Stage3 |
4.820400E-01 |
| Stage1-vs-Stage4 |
3.579400E-01 |
| Stage2-vs-Stage3 |
8.202400E-01 |
| Stage2-vs-Stage4 |
6.264000E-01 |
| Stage3-vs-Stage4 |
7.232400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.14039999999471E-05 |
| Normal-vs-AfricanAmerican |
1.495000E-01 |
| Normal-vs-Asian |
3.197500E-03 |
| Caucasian-vs-AfricanAmerican |
1.359020E-01 |
| Caucasian-vs-Asian |
6.985400E-01 |
| AfricanAmerican-vs-Asian |
3.115400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.00440000000624E-06 |
| Normal-vs-Female |
9.80859999999417E-05 |
| Male-vs-Female |
2.620600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.249300E-04 |
| Normal-vs-Age(41-60Yrs) |
7.91310000000101E-05 |
| Normal-vs-Age(61-80Yrs) |
3.87490000000046E-05 |
| Normal-vs-Age(81-100Yrs) |
8.021700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.693600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.702400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.608400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.209400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.580600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.400600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.509000E-01 |
| Classical-VS-Follicular |
1.375710E-02 |
| Classical-VS-Other |
8.148300E-02 |
| Classical-VS-Normal |
4.551700E-04 |
| Tall-VS-Follicular |
2.322600E-01 |
| Tall-VS-Other |
2.014600E-01 |
| Tall-VS-Normal |
3.998700E-03 |
| Follicular-VS-Other |
5.920400E-01 |
| Follicular-VS-Normal |
3.30650000002208E-06 |
| Other-VS-Normal |
3.618400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.29410000004881E-06 |
| Normal-vs-N1 |
1.78269999999703E-05 |
| N0-vs-N1 |
3.232800E-01 |
|
|
